Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-05-04
1989-02-21
Siegel, Alan
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142282, 514253, 514321, 544146, 544317, 546197, 549 50, A61K 3138, C07D49502
Patent
active
048065625
ABSTRACT:
Thieno[2,3-b]thiophene-2-sulfonamides are carbonic anhydrase inhibitors useful in the treatment of elevated intraocular pressure and glaucoma.
REFERENCES:
patent: 3733322 (1973-05-01), Wright
patent: 4668697 (1987-05-01), Shepard et al.
Kvitko et al, J. Org. Chem. 12, 1550 (1976).
Hartman George D.
Prugh John D.
Merck & Co. , Inc.
Nicholson William H.
Siegel Alan
Sudol, Jr. Michael C.
LandOfFree
Substituted thieno[2,3-b]thiophene-2-sulfonamides as antiglaucom does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted thieno[2,3-b]thiophene-2-sulfonamides as antiglaucom, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted thieno[2,3-b]thiophene-2-sulfonamides as antiglaucom will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1522572